# MediCare Phase 16 Completion Report

**Author:** Manus AI  
**Phase:** 16 — AI Capability, Dataset & Algorithm Finalization  
**Project:** MediCare — Intelligent Clinical Decision Support System  
**Scope:** Planning/specification and AI decision-unblocking only  

> **STATUS = READY FOR PHASE 17 MODEL IMPLEMENTATION**

No model was trained. No dataset was downloaded. No preprocessing was fitted. No prediction, confidence score, evaluation metric, model artifact, AI endpoint, chatbot, RAG system, LLM, external AI provider, database migration, or frontend AI integration was created.

## 1. Phase status

Phase 16 is complete. The project has one evidence-backed first AI capability, one recommended public dataset with an official source and verified CC BY 4.0 statement, an exact feature/target contract, a primary algorithm decision, a future evaluation and safety plan, a future API/frontend/database plan, completed SRS traceability, a formal decision log, and validation evidence. The work stops before Phase 17 as required.

## 2. Previous blocker analysis

Phases 12, 13, and 15 correctly remained blocked because the project had no selected capability, exact problem definition, approved dataset, verified licensing/authorization, feature schema, target, algorithm, or implementation authorization. Phase 16 resolves the specification ambiguity by selecting one bounded academic task and identifying a legitimate public source. It does not imply that project-owner training authorization or runtime clinical approval has been granted.

## 3. SRS findings

The SRS and prior AI documentation identify symptom analysis, disease/risk prediction, medical-report analysis, medicine information, drug interaction detection, and health recommendations as candidate capabilities. The SRS does not provide a finalized first capability, labeled training corpus, target policy, or clinical deployment authorization. The current Patient AI Insights page is a deferred/non-predictive interface and was not modified.

The selected capability is therefore traced to the SRS’s disease/risk-prediction candidate and constrained to a public-dataset label-classification demonstration. Where the SRS is silent, the report and specification explicitly state that the item is **not specified in the SRS** and requires later approval.

## 4. Current project findings

The current implementation is a Django 5.2.17/DRF 3.18.0 backend with session/CSRF authentication, patient, doctor, appointment, clinical-data, and Admin modules, plus a static HTML/CSS/Vanilla JavaScript frontend. The AI directory contains fail-closed foundation contracts and historical blocked-path tests but no model runtime. Existing database models contain operational MediCare application data; they are not an approved ML dataset and were not used.

The current project contains no approved dataset file, no model artifact, no AI route, no external AI provider integration, and no ML dependency. The selected future workflow remains offline and disconnected from MediCare patient data.

## 5. Candidate AI capabilities

The decision matrix considered disease-risk classification, symptom-based risk classification, medical-report classification, heart-failure survival classification, diabetes health classification, and appointment no-show prediction. It assessed SRS alignment, dataset availability and licensing, target clarity, feature availability, algorithm suitability, evaluation feasibility, implementation complexity, healthcare safety, academic value, and integration feasibility.

| Candidate | Decision | Principal reason |
|---|---|---|
| Academic disease-risk classification | **Selected** | Direct SRS alignment, bounded tabular input/output, documented public classification source, reproducible evaluation, and manageable safety boundary |
| Symptom-based risk classification | Rejected | No approved structured symptom schema, label corpus, or escalation policy |
| Medical-report classification | Rejected | No approved annotated/licensed report corpus or annotation protocol |
| Heart-failure survival classification | Rejected | Narrower cohort and greater risk of unsupported prognosis claims |
| CDC diabetes health classification | Rejected | Official UCI page points to linked-source licensing requiring separate verification; sensitive survey features need additional governance |
| Appointment no-show prediction | Rejected | No approved historical no-show label and not explicitly required by the SRS |

The complete comparison is in `docs/AI_CAPABILITY_DECISION_MATRIX.md`.

## 6. Final capability decision

**Capability:** Academic disease-risk classification using the UCI Heart Disease dataset label.

**Problem statement:** Given one approved public-dataset row containing the exact 13-feature allow-list, classify whether the source UCI `num` label is absent (`0`) or present (`1–4`). The output is a classification of a public dataset label, not a diagnosis or patient-specific medical risk.

**Intended purpose:** Demonstrate a reproducible, interpretable, non-autonomous classification workflow for academic evaluation.

**Intended users:** Developers, researchers, and explicitly authorized academic reviewers during offline Phase 17 work. Patients, doctors, and Administrators do not receive model output in Phase 16.

**Input:** The 13 approved UCI features documented below. No MediCare patient ID, clinical-record ID, arbitrary file, or operational database row is accepted.

**Output:** A future model-generated dataset-label class, `label_absent` or `label_present`, with an academic-only disclaimer. Probability/confidence is not exposed by default.

**Prediction type:** Binary supervised classification.

**Fit to MediCare:** The task corresponds to the SRS disease/risk-prediction candidate while remaining bounded enough for a small academic prototype. It can be developed without real MediCare patient data and without autonomous clinical action.

**Limitations:** The UCI cohort is small, historical, source-specific, and not representative of MediCare users. Missing values are documented. The transformed target is a dataset label. No clinical validity, generalization, or production readiness is claimed.

## 7. Dataset decision

**Selected source:** UCI Heart Disease, UCI Machine Learning Repository dataset 45, DOI `10.24432/C52P4X`, [official UCI page][1].

The official page documents 303 instances, 13 commonly used features, categorical/integer/real feature types, a classification task, missing values, and the `num` target convention [1]. It also states that names and social-security numbers were removed or replaced with dummy values; Phase 17 must still inspect the exact retrieved file before use.

| Dataset | Target | Features/size | License | Quality | Suitability | Decision |
|---|---|---:|---|---|---|---|
| UCI Heart Disease | `num`: 0 versus 1–4 | 13 common features; 303 instances | CC BY 4.0 stated on official UCI page | Missing values documented; compact schema; source target documented | Strong fit for bounded academic classification | **Selected** |
| UCI Heart Failure Clinical Records | `DEATH_EVENT` | 12 features plus target; 299 instances | CC BY 4.0 stated on official UCI page | No missing values documented; narrow heart-failure survival cohort | Technically clean but more likely to imply prognosis | Rejected |
| UCI CDC Diabetes Health Indicators | Diabetes/pre-diabetes/healthy classes | 21 features; 253,680 instances | UCI page points to a linked source for licensing | Large survey dataset with sensitive demographic/economic fields | License/authorization and governance incomplete | Rejected |

No dataset was downloaded or copied into the project.

## 8. Dataset source, license, and suitability

The official UCI page states **Creative Commons Attribution 4.0 International (CC BY 4.0)**. The [CC BY 4.0 legal code][2] permits reproduction/sharing and adaptation subject to attribution, license notice, modification notice where applicable, and the license’s other conditions. Academic use is permitted within those conditions; modification and redistribution are permitted within those conditions. The official UCI page did not identify a separate project-specific permission requirement, but Phase 17 must obtain project-owner authorization and check any accompanying files for different terms.

The Phase 17 attribution plan must preserve the UCI dataset name, authors/source citation as provided by UCI, DOI, official URL, CC BY 4.0 link, license notice, and a notice describing any transformation, including the `num` to binary-label derivation. The source license does not create clinical validity, institutional approval, or permission to use MediCare patient data.

## 9. Feature schema

The exact future feature allow-list is `age`, `sex`, `cp`, `trestbps`, `chol`, `fbs`, `restecg`, `thalach`, `exang`, `oldpeak`, `slope`, `ca`, and `thal`.

| Feature | Type | Meaning | Validation/preprocessing | MediCare exposure |
|---|---|---|---|---|
| `age` | Numeric integer | Age in years | Plausible-range validation; training-only median imputation and scaling | Offline only |
| `sex` | Binary/categorical | Source-coded sex value | Explicit source-code mapping; subgroup review | Offline only; restricted subgroup analysis |
| `cp` | Categorical | Chest-pain type, source categories 1–4 | Reject unknown codes; one-hot encode | Offline only |
| `trestbps` | Numeric integer | Resting blood pressure in mm Hg | Range validation; training-only median imputation and scaling | Offline only |
| `chol` | Numeric integer | Serum cholesterol in mg/dl | Range validation; training-only median imputation and scaling | Offline only |
| `fbs` | Binary/categorical | Fasting blood sugar indicator | Explicit mapping; reject invalid codes | Offline only |
| `restecg` | Categorical | Resting ECG result | Explicit source-code validation; one-hot encode | Offline only |
| `thalach` | Numeric integer | Maximum heart rate achieved | Range validation; training-only median imputation and scaling | Offline only |
| `exang` | Binary/categorical | Exercise-induced angina indicator | Explicit mapping; reject invalid codes | Offline only |
| `oldpeak` | Numeric | ST depression relative to rest | Finite/range validation; training-only median imputation and scaling | Offline only |
| `slope` | Categorical | Peak exercise ST-segment slope, source categories 1–3 | Reject unknown codes; one-hot encode | Offline only |
| `ca` | Categorical/ordinal | Number of major vessels, 0–3 | Validate 0–3; source missingness reviewed; training-only imputation | Offline only |
| `thal` | Categorical | Source-coded thalassemia result | Explicit mapping; source missingness reviewed; training-only imputation/encoding | Offline only |

Required fields are not optional in the future request contract. No names, addresses, phones, emails, dates of birth, social-security numbers, IDs, medical-record IDs, MediCare identifiers, or Django clinical-table fields are features.

## 10. Target variable and labels

**Target:** `disease_label_present`.

```text
source num == 0       -> 0 (source label absent)
source num in 1..4    -> 1 (source label present)
missing/other value   -> invalid record; report and reject under frozen protocol
```

The target is binary and represents a public dataset label. It must never be called a diagnosis, disease confirmation, prognosis, or patient risk assessment. Phase 17 must report class distribution, invalid labels, missing targets, duplicates, exclusions, and any imbalance before fitting.

## 11. Algorithm comparison and final algorithm

| Algorithm | Advantages | Disadvantages | Interpretability | Suitability | Decision |
|---|---|---|---|---|---|
| Logistic Regression | Binary-task fit, low compute, coefficient associations, reproducible | Linear boundary; calibration must be assessed | High relative to alternatives, not causal | Strong for compact academic baseline | **Primary** |
| Shallow Decision Tree | Readable split paths; mixed-data support | Unstable, overfitting, apparent certainty | Moderate; paths are not medical reasoning | Useful comparison only | Secondary comparison |
| Random Forest | Nonlinear interactions; robust tabular baseline | Lower transparency; calibration/explanation burden | Lower; importance is not causality | Possible comparison, not first choice | Rejected as primary |
| Gradient Boosting | Strong tabular potential | Tuning and governance burden | Lower | Unnecessary for first conservative task | Rejected |

**PRIMARY ALGORITHM:** Logistic Regression.  
**WHY:** It matches the binary problem, compact mixed-type feature schema, small academic dataset, interpretability requirements, low implementation complexity, and healthcare-safety preference for a conservative first baseline.  
**ALTERNATIVES REJECTED AS PRIMARY:** Shallow Decision Tree, Random Forest, and Gradient Boosting.  
**REASON:** They add instability, nonlinear opacity, calibration burden, or tuning complexity without a Phase 16 evidence basis for preferring them. No algorithm was trained or benchmarked.

## 12. Baseline

The future baseline is a majority-class classifier computed from training labels only. It uses the same held-out test set and folds as Logistic Regression. It is specified for Phase 17 evaluation and was not trained in Phase 16.

## 13. Preprocessing plan

Phase 17 must verify required columns, reject unknown fields, remove residual identifiers before splitting, validate target and feature codes/ranges, audit duplicates, and report row counts before and after each exclusion. Numeric missing values use training-only median imputation and training-only scaling. Categorical missing values use a predeclared training-only imputation/unknown policy and one-hot encoding. No test/validation statistic may affect preprocessing. No resampling or class weighting is applied in Phase 16; if class imbalance is material, a mitigation must be predeclared and evaluated inside training folds only.

## 14. Train/test strategy

Use a fixed, reproducible stratified 80/20 holdout for final evaluation, with fixed stratified cross-validation inside the training set for baseline/model decisions. Freeze the random seed, fold count, feature order, preprocessing, and threshold policy before opening final test labels. Audit duplicates/near-duplicates before splitting. If repeated-patient structure exists in the retrieved file, use an appropriate group split; never use the identifier as a feature. Keep the final test set untouched until all decisions are frozen.

## 15. Evaluation metrics

Future evaluation should report the majority-class baseline alongside Logistic Regression using balanced accuracy, accuracy as context, precision, recall/sensitivity, specificity, F1, ROC-AUC where valid, PR-AUC where useful under imbalance, confusion matrix, and calibration review before any probability-like output. These metrics expose false-negative and false-positive behavior and avoid relying on raw accuracy alone. No metric values were produced in Phase 16.

## 16. Explainability plan

Use signed Logistic Regression coefficient associations mapped back to source feature names after preprocessing. Explain model behavior, not medical reasoning or causality. A future explanation must include model version, preprocessing version, accepted feature names/values, output label, and a fixed disclaimer. SHAP/LIME are not required for the primary model. The explanation path must fail closed for invalid input, schema mismatch, missing artifacts, or version mismatch.

## 17. Bias and fairness plan

Before training, report source population/context, age and sex representation, class distribution, missingness, duplicates, and data exclusions. Sex is a potential subgroup-analysis dimension only where sample sizes and privacy review support it. Report subgroup sample sizes and appropriate metrics with uncertainty where feasible; do not publish unstable estimates. Document historical sampling bias, label bias, measurement differences, missingness, and distribution shift. No fairness metric or subgroup result is claimed in Phase 16.

## 18. Healthcare safety plan

The model is an academic software component, not a medical device or clinical decision-maker. It must not diagnose, prescribe, recommend treatment autonomously, replace a doctor, modify records, order tests, make emergency decisions, or make irreversible medical decisions. Any future result must be labeled model-generated informational assistance and state that it is not a diagnosis or medical advice.

The future path must abstain or return `unsupported`/`invalid` for missing, malformed, out-of-range, unknown, unavailable, mismatched, or out-of-scope input. It must remain offline and disconnected from MediCare patient inference unless a later phase explicitly authorizes privacy, clinical, security, safety, human-review, and UI integration.

## 19. Future API contract

**FUTURE / PHASE 17+ API — not implemented in Phase 16.**

```text
POST /api/ai/disease-risk/classify/
```

The future endpoint would be developer/Admin-gated, authenticated, server-authorized, CSRF-protected where applicable, rate-limited, serializer-validated, and restricted to the 13-feature schema. It must not accept patient IDs, clinical-record IDs, raw files, arbitrary model paths, or arbitrary feature dictionaries.

A safe future response is:

```json
{
  "status": "supported|unsupported|invalid",
  "task": "academic_disease_label_classification",
  "model_version": "uci-heart-disease-logreg-v1.0.0",
  "output_label": "label_absent|label_present",
  "explanation": [],
  "disclaimer": "Model-generated academic result; not a diagnosis or medical advice."
}
```

No probability/confidence field is included by default. It may be considered only after calibration, uncertainty review, and explicit authorization. Errors must be safe, explicit, and non-fabricating.

## 20. Future Patient AI Insights integration

The Patient AI Insights page remains unchanged and non-predictive in Phase 16. A later phase may evaluate an informational result card only after API authorization, role/privacy review, safe copy review, human oversight, and a separate decision about patient-facing use. No emergency or treatment call-to-action is permitted.

## 21. Future Admin integration

No Admin AI management is implemented. If later justified, an Admin-only operations view may expose model status, model version, dataset identifier/hash, evaluation-report location, and safety-review status. It must not expose raw dataset rows, patient data, secrets, arbitrary artifact paths, or a claim of clinical approval.

## 22. Database implications

No database change is required for offline Phase 17 training. No migration or model modification was made in Phase 16. If later audit persistence is approved, a separate versioned non-clinical audit entity could store model version, preprocessing version, request status, timestamp, and safe operational metadata without raw feature payloads by default. That requires a separate privacy, security, and migration review.

## 23. Dependencies

Phase 16 added no ML dependency. Phase 17 should add only the minimal pinned scientific packages genuinely required after environment review, likely the project-approved versions of NumPy, pandas, and scikit-learn. No external AI provider, cloud API, LLM, RAG, or model-hosting dependency is authorized.

## 24. Reproducibility

Phase 17 must record UCI source URL, DOI, license, exact dataset file/version/hash, citation, preprocessing version/configuration, feature order, target transform, random seed, split/fold protocol, algorithm settings/hyperparameters, Python version, dependency versions/lock, evaluation script version, and artifact checksum. A clean-room run must not require MediCare patient data.

## 25. Model versioning

The proposed future identifier is `uci-heart-disease-logreg-v1.0.0`. A future model card must include model version, dataset version/hash, training date, preprocessing version, code commit, dependency manifest, hyperparameters, evaluation report, and safety-review state. Any change to the dataset, feature schema, target transformation, preprocessing, algorithm, or threshold invalidates prior claims and increments the appropriate version.

## 26. SRS traceability

`docs/AI_SRS_TRACEABILITY.md` maps the disease-risk candidate to the selected academic classification task, official UCI source, target transform, feature schema, Logistic Regression decision, preprocessing, evaluation, explainability, safety, and deferred API/frontend work. It also preserves historical blocked outcomes for the other candidates. Items not specified in the SRS are explicitly marked as needing later approval rather than silently invented.

## 27. Decision log

`docs/PHASE16_AI_DECISION_LOG.md` records the selected capability, rejected capabilities, selected/rejected datasets, selected/rejected algorithms, target, features, evaluation strategy, safety boundaries, remaining risks, assumptions, and unresolved questions.

## 28. Remaining risks, assumptions, and blockers

Remaining risks include small-sample uncertainty, historical and sampling bias, missingness, target-label limitations, distribution shift, subgroup underrepresentation, calibration uncertainty, and the risk that users interpret a dataset-label classifier as medical advice. Phase 16 assumes the UCI page and stated license remain the governing source when Phase 17 retrieves the data and that the workflow remains academic/offline.

Remaining blockers to training are final project-owner authorization to download/use the dataset, Phase 17 verification of the exact file/version/hash/schema/missingness/duplicates/target distribution, final dependency pinning, and the pre-training safety/privacy gate. These are intentional gates, not missing specification items.

## 29. Phase 17 readiness gate

| Gate | Required evidence before training |
|---|---|
| Capability | Owner confirms the single selected task |
| Dataset access | Explicit retrieval/use authorization |
| Source/license | UCI URL, DOI, CC BY 4.0 notice, attribution plan |
| Data verification | Exact file/hash, schema, row count, missingness, duplicates, target distribution |
| Privacy | No MediCare patient data; identifier removal confirmed |
| Feature/target | Exact mapping and invalid-value policy reviewed |
| Algorithm | Logistic Regression selection confirmed |
| Evaluation | Split/seed/metrics protocol frozen before training |
| Safety | Academic-only, non-diagnostic, no endpoint by default |
| Reproducibility | Pinned environment and artifact-storage plan |

## 30. Exact validation results

| Validation | Result |
|---|---|
| AI foundation, Phase 12, Phase 15, and Phase 16 unittest suite | **25 tests passed**, 0 failures, 0 errors |
| Django/Admin/patient/doctor/appointment/clinical regression suite | **58 tests passed**, 0 failures, 0 errors |
| Combined executed test count | **83 tests passed** across the two suites |
| `manage.py check` | Passed: no issues, 0 silenced |
| `makemigrations --check --dry-run` | Passed: no changes detected |
| Python compilation | Passed for `backend` and `ai` |
| JavaScript syntax | Passed for all frontend `.js` files checked with `node --check` |
| Frontend HTML/CSS local-reference validation | Passed: 142 local references checked, 0 broken references |
| Documentation consistency checks | Passed: required status, dataset, license, target, algorithm, baseline, API-plan, database-plan, and Phase 16 markers found |
| AI route scan | Passed: no runtime `api/ai/` or `api/chat/` route definitions; only negative assertions in tests |
| Secret scan | Passed for private-key/provider-key patterns; test passwords are intentional fixtures only |
| AI artifact/dataset scan | Passed: no model artifacts or downloaded dataset files found outside generated caches/logs |
| PostgreSQL | Not installed/accessed/tested, as required; Django tests used the project’s isolated test configuration |

The authoritative logs are included in `docs/phase16-*.log` files in the package.

## 31. Project integrity against Phase 15

The baseline was `/home/ubuntu/upload/medicare_phase15_completed.zip`. Normalized comparison excluded generated Python caches and the generated local SQLite test database.

| Area | Result |
|---|---|
| Frontend | **Unchanged**; `diff -qr` reported no differences |
| Backend application source | **Unchanged**; `diff -qr` reported no differences after excluding `venv`, `__pycache__`, and generated `db.sqlite3` |
| Normalized protected frontend/backend checksum | Identical on both sides: `89630fcc4c4e0e00c6f814bbf44704457c7414e35054f6fe031e32cafbf355fd` |
| AI/docs | Only the listed Phase 16 specification, traceability, decision-log, roadmap, test, and validation files changed or were added |
| Database models/migrations | Unchanged; migration drift check passed |

## 32. Files created

| File | Purpose |
|---|---|
| `PHASE16_COMPLETION_REPORT.md` | This completion report |
| `docs/PHASE16_AI_SPECIFICATION.md` | Complete implementation-ready future AI specification |
| `docs/PHASE16_AI_DECISION_LOG.md` | Formal Phase 16 decision log |
| `docs/AI_CAPABILITY_DECISION_MATRIX.md` | Candidate capability and dataset decision matrix |
| `docs/phase16-dataset-research.md` | Official-source dataset research notes |
| `docs/PHASE17_API_FRONTEND_PLAN.md` | Deferred future API/frontend/database integration plan |
| `ai/algorithms/PHASE17_ALGORITHM_SELECTION.md` | Logistic Regression selection record |
| `ai/preprocessing/PHASE17_FEATURE_SCHEMA.md` | Exact Phase 17 feature contract |
| `ai/models/PHASE17_EVALUATION_PLAN.md` | Task-specific evaluation protocol |
| `ai/models/PHASE17_EXPLAINABILITY_PLAN.md` | Coefficient-based explanation plan |
| `ai/safety/PHASE17_CLINICAL_SAFETY.md` | Future clinical safety boundaries |
| `ai/tests/test_phase16_specification.py` | Four Phase 16 consistency/scope tests |
| `docs/validate_frontend_refs.py` | Saved deterministic HTML/CSS local-reference validator |
| `docs/phase16-ai-unittest.log` | AI test evidence |
| `docs/phase16-django-validation.log` | Django check/migration/regression evidence |
| `docs/phase16-static-validation.log` | Python/JavaScript/frontend inventory evidence |
| `docs/phase16-frontend-reference-validation.log` | Frontend reference evidence |
| `docs/phase16-security-scope-narrow.log` | Security/scope scan evidence |
| `docs/phase16-integrity-protected.log` | Phase 15 protected-integrity evidence |
| `docs/phase16-final-validation.log` | Final AI/documentation consistency evidence |

## 33. Files modified

The following existing files were minimally updated by appending Phase 16 addenda or final status changes while preserving historical blocked decisions:

| File | Modification |
|---|---|
| `ai/algorithms/ALGORITHM_SELECTION.md` | Added final capability/algorithm decision addendum |
| `ai/datasets/DATASET_SPECIFICATION.md` | Added UCI Heart Disease recommendation, target, schema, license, and Phase 17 recheck gate |
| `ai/preprocessing/FEATURE_SCHEMA.md` | Added UCI feature allow-list and preprocessing contract |
| `ai/models/EVALUATION_PLAN.md` | Added task-specific split, baseline, metrics, and leakage plan |
| `ai/models/BIAS_FAIRNESS_PLAN.md` | Added UCI representation/subgroup/missingness considerations |
| `ai/models/MODEL_CARD.md` | Added pending Logistic Regression model-card specification |
| `ai/safety/CLINICAL_SAFETY_PLAN.md` | Added academic-only heart-disease-label safety boundaries |
| `docs/AI_SRS_TRACEABILITY.md` | Added Phase 16 SPECIFIED mapping and Phase 17 readiness status |
| `docs/AI_ROADMAP.md` | Marked Phase 16 complete and Phase 17 gated/not started |

No frontend file, backend application file, database model, migration, requirements file, authentication file, Admin module file, or URL configuration file was modified.

## 34. Files deleted

No project source, documentation, frontend, backend, model, migration, or test file was deleted. Generated `backend/db.sqlite3` and superseded temporary validation logs were removed during cleanup; neither was part of the Phase 15 protected application baseline or final deliverable source.

## 35. Important unchanged files

The following categories remained unchanged and were verified against the Phase 15 package: all `frontend/` pages, stylesheets, and JavaScript; all backend apps, serializers, permissions, views, URLs, models, and migrations; Admin module source; authentication/CSRF implementation; `backend/requirements.txt`; AI foundation runtime interfaces; and the existing Phase 12/15 blocked-path tests. No PostgreSQL installation or external database access occurred.

## 36. Remaining risks

The future task remains vulnerable to small-sample uncertainty, historical/sampling bias, missingness, target-label limitations, distribution shift, subgroup underrepresentation, calibration uncertainty, and misinterpretation as medical advice. A public license does not establish clinical validity or institutional approval.

## 37. Remaining assumptions

The specification assumes that the UCI page and its stated CC BY 4.0 terms remain available at Phase 17 retrieval, that the project remains academic/offline, and that no MediCare patient data enters the workflow. The final file/version/hash and dependency pins are intentionally deferred until retrieval is authorized.

## 38. Remaining blockers

The specification is ready, but Phase 17 must not train until project-owner retrieval/training authorization is recorded, the exact UCI file is obtained and verified, the source/license/attribution gate is rechecked, the data-quality report is complete, the evaluation protocol is frozen, and the safety/privacy gate passes. These are explicit pre-training controls rather than unresolved Phase 16 design ambiguity.

## 39. Phase 17 readiness status

> **STATUS = READY FOR PHASE 17 MODEL IMPLEMENTATION**

This status means the implementation plan is complete. It does not mean a trained model exists, that the dataset is in the repository, that performance is known, or that clinical deployment is authorized.

## 40. PostgreSQL restriction confirmation

PostgreSQL was not installed in the sandbox. The Windows PostgreSQL instance was not accessed. No claim is made that Windows PostgreSQL was tested, and no user database was modified.

## 41. Strict stop condition

Phase 16 ends here. Phase 17 was not started. No model implementation, model training, dataset download, API creation, frontend integration, database migration, chatbot, RAG, LLM, or external AI provider work was performed.

## References

[1]: https://archive.ics.uci.edu/dataset/45/heart+disease "UCI Heart Disease dataset"
[2]: https://creativecommons.org/licenses/by/4.0/legalcode "Creative Commons Attribution 4.0 International legal code"
[3]: https://archive.ics.uci.edu/dataset/519/heart+failure+clinical+records "UCI Heart Failure Clinical Records dataset"
[4]: https://archive.ics.uci.edu/dataset/891/cdc+diabetes+health+indicators "UCI CDC Diabetes Health Indicators dataset"
[5]: ../upload/pasted_content_17.txt "Authoritative Phase 16 prompt"
[6]: ../upload/pasted_content_18.txt "Phase 16 execution instruction"
